XIAP is a copper binding protein deregulated in Wilson's disease and other copper toxicosis disorders

Arjmand R. Mufti, Ezra Burstein, Rebecca A. Csomos, Paul C F Graf, John C. Wilkinson, Robert D. Dick, Madhavi Challa, Jae Kyoung Son, Shawn B. Bratton, Grace L. Su, George J. Brewer, Ursula Jakob, Colin S. Duckett

Research output: Contribution to journalArticle

127 Citations (Scopus)

Abstract

X-linked inhibitor of apoptosis (XIAP), known primarily for its caspase inhibitory properties, has recently been shown to interact with and regulate the levels of COMMD1, a protein associated with a form of canine copper toxicosis. Here, we describe a role for XIAP in copper metabolism. We find that XIAP levels are greatly reduced by intracellular copper accumulation in Wilson's disease and other copper toxicosis disorders and in cells cultured under high copper conditions. Elevated copper levels result in a profound, reversible conformational change in XIAP due to the direct binding of copper to XIAP, which accelerates its degradation and significantly decreases its ability to inhibit caspase-3. This results in a lowering of the apoptotic threshold, sensitizing the cell to apoptosis. These data provide an unsuspected link between copper homeostasis and the regulation of cell death through XIAP and may contribute to the pathophysiology of copper toxicosis disorders.

Original languageEnglish (US)
Pages (from-to)775-785
Number of pages11
JournalMolecular Cell
Volume21
Issue number6
DOIs
StatePublished - Mar 17 2006

Fingerprint

Hepatolenticular Degeneration
Copper
Apoptosis
copper-binding protein
Caspases
Caspase 3
Canidae
Cultured Cells
Homeostasis
Cell Death

ASJC Scopus subject areas

  • Molecular Biology

Cite this

XIAP is a copper binding protein deregulated in Wilson's disease and other copper toxicosis disorders. / Mufti, Arjmand R.; Burstein, Ezra; Csomos, Rebecca A.; Graf, Paul C F; Wilkinson, John C.; Dick, Robert D.; Challa, Madhavi; Son, Jae Kyoung; Bratton, Shawn B.; Su, Grace L.; Brewer, George J.; Jakob, Ursula; Duckett, Colin S.

In: Molecular Cell, Vol. 21, No. 6, 17.03.2006, p. 775-785.

Research output: Contribution to journalArticle

Mufti, AR, Burstein, E, Csomos, RA, Graf, PCF, Wilkinson, JC, Dick, RD, Challa, M, Son, JK, Bratton, SB, Su, GL, Brewer, GJ, Jakob, U & Duckett, CS 2006, 'XIAP is a copper binding protein deregulated in Wilson's disease and other copper toxicosis disorders', Molecular Cell, vol. 21, no. 6, pp. 775-785. https://doi.org/10.1016/j.molcel.2006.01.033
Mufti, Arjmand R. ; Burstein, Ezra ; Csomos, Rebecca A. ; Graf, Paul C F ; Wilkinson, John C. ; Dick, Robert D. ; Challa, Madhavi ; Son, Jae Kyoung ; Bratton, Shawn B. ; Su, Grace L. ; Brewer, George J. ; Jakob, Ursula ; Duckett, Colin S. / XIAP is a copper binding protein deregulated in Wilson's disease and other copper toxicosis disorders. In: Molecular Cell. 2006 ; Vol. 21, No. 6. pp. 775-785.
@article{c7f396e512a6489184f36e50615cac1b,
title = "XIAP is a copper binding protein deregulated in Wilson's disease and other copper toxicosis disorders",
abstract = "X-linked inhibitor of apoptosis (XIAP), known primarily for its caspase inhibitory properties, has recently been shown to interact with and regulate the levels of COMMD1, a protein associated with a form of canine copper toxicosis. Here, we describe a role for XIAP in copper metabolism. We find that XIAP levels are greatly reduced by intracellular copper accumulation in Wilson's disease and other copper toxicosis disorders and in cells cultured under high copper conditions. Elevated copper levels result in a profound, reversible conformational change in XIAP due to the direct binding of copper to XIAP, which accelerates its degradation and significantly decreases its ability to inhibit caspase-3. This results in a lowering of the apoptotic threshold, sensitizing the cell to apoptosis. These data provide an unsuspected link between copper homeostasis and the regulation of cell death through XIAP and may contribute to the pathophysiology of copper toxicosis disorders.",
author = "Mufti, {Arjmand R.} and Ezra Burstein and Csomos, {Rebecca A.} and Graf, {Paul C F} and Wilkinson, {John C.} and Dick, {Robert D.} and Madhavi Challa and Son, {Jae Kyoung} and Bratton, {Shawn B.} and Su, {Grace L.} and Brewer, {George J.} and Ursula Jakob and Duckett, {Colin S.}",
year = "2006",
month = "3",
day = "17",
doi = "10.1016/j.molcel.2006.01.033",
language = "English (US)",
volume = "21",
pages = "775--785",
journal = "Molecular Cell",
issn = "1097-2765",
publisher = "Cell Press",
number = "6",

}

TY - JOUR

T1 - XIAP is a copper binding protein deregulated in Wilson's disease and other copper toxicosis disorders

AU - Mufti, Arjmand R.

AU - Burstein, Ezra

AU - Csomos, Rebecca A.

AU - Graf, Paul C F

AU - Wilkinson, John C.

AU - Dick, Robert D.

AU - Challa, Madhavi

AU - Son, Jae Kyoung

AU - Bratton, Shawn B.

AU - Su, Grace L.

AU - Brewer, George J.

AU - Jakob, Ursula

AU - Duckett, Colin S.

PY - 2006/3/17

Y1 - 2006/3/17

N2 - X-linked inhibitor of apoptosis (XIAP), known primarily for its caspase inhibitory properties, has recently been shown to interact with and regulate the levels of COMMD1, a protein associated with a form of canine copper toxicosis. Here, we describe a role for XIAP in copper metabolism. We find that XIAP levels are greatly reduced by intracellular copper accumulation in Wilson's disease and other copper toxicosis disorders and in cells cultured under high copper conditions. Elevated copper levels result in a profound, reversible conformational change in XIAP due to the direct binding of copper to XIAP, which accelerates its degradation and significantly decreases its ability to inhibit caspase-3. This results in a lowering of the apoptotic threshold, sensitizing the cell to apoptosis. These data provide an unsuspected link between copper homeostasis and the regulation of cell death through XIAP and may contribute to the pathophysiology of copper toxicosis disorders.

AB - X-linked inhibitor of apoptosis (XIAP), known primarily for its caspase inhibitory properties, has recently been shown to interact with and regulate the levels of COMMD1, a protein associated with a form of canine copper toxicosis. Here, we describe a role for XIAP in copper metabolism. We find that XIAP levels are greatly reduced by intracellular copper accumulation in Wilson's disease and other copper toxicosis disorders and in cells cultured under high copper conditions. Elevated copper levels result in a profound, reversible conformational change in XIAP due to the direct binding of copper to XIAP, which accelerates its degradation and significantly decreases its ability to inhibit caspase-3. This results in a lowering of the apoptotic threshold, sensitizing the cell to apoptosis. These data provide an unsuspected link between copper homeostasis and the regulation of cell death through XIAP and may contribute to the pathophysiology of copper toxicosis disorders.

UR - http://www.scopus.com/inward/record.url?scp=33644857818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644857818&partnerID=8YFLogxK

U2 - 10.1016/j.molcel.2006.01.033

DO - 10.1016/j.molcel.2006.01.033

M3 - Article

C2 - 16543147

AN - SCOPUS:33644857818

VL - 21

SP - 775

EP - 785

JO - Molecular Cell

JF - Molecular Cell

SN - 1097-2765

IS - 6

ER -